Ichor Medical Systems is a biotech company developing products based on the in vivo application of electroporation. It enhances intracellular delivery of nucleic acid-based drugs encoding therapeutic proteins, antigens for vaccines, or antibodies for passive immunity, to treat and prevent debilitating or life-threatening diseases. The company develops TriGrid Delivery System for electroporation-mediated in vivo nucleic acid administration, enabling control of the site of injection, placement of electrodes, rate of agent administration, and timing of electroporation delivery.